Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diclofenac in acute submassive pulmonary embolism
NCT01590342Phase 3Terminated
- Sponsor
- Ministry of Health
- Start
- May 2012
- Primary completion
- Jan 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of diclofenac in pulmonary embolism (PE), sponsored by Ministry of Health. Primary endpoint: Right ventricular dysfunction. Started May 2012; status: terminated.
02
Drugs
diclofenac
03
Conditions
pulmonary embolism (PE)
Beyond the preview
Go deeper on NCT01590342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01590342.